Complying with USP <467> and ICH Q3C methods.

Solvents are often necessary for the manufacture of drug products, as they can improve yield and solubility and enhance crystallization. However, depending on their toxicity and concentration, they can be harmful to the patient. Determination of residual solvents is critical to ensure that pharmaceutical raw materials and finished products are safe.

Exova conducts residual solvent testing in compliance with USP <467> and ICH Q3C. Most of the residual solvents listed can be determined by USP <467> and ICH Q3C while some others require methods to be developed specifically and validated. Exova also offers testing by our internal GCMS methods. 

Working closely with our clients, we look for potential sources of solvent contamination, assist in working to eliminate these from your products and help to resolve difficult out of specification issues related to solvents. The USP <467> and ICH Q3C residual solvents methods can be performed on a rush basis to meet your business needs.

  • Contact Us

    Whatever your query, we'll pass it on to our experts and respond within a very short space of time.
    More details
Pharmaceutical testing facilities

2395 Speakman Dr.,
Mississauga, ON L5K 1B3

Contact: Larissa Hillar - Operations Manager
Tel: +1 905 822 4111

Fax: +1 905 823 1446

Email: americas@exova.com

Click to view dynamic map

9240 Santa Fe Springs Road,
Santa Fe Springs, CA 90670

Contact: Eric Lindsay - General Manager
Tel: +1 562 948 2225

Fax: +1 562 948 5850

Email: americas@exova.com

Capabilities
Click to view dynamic map

Plot 598-221, Dubai Investments Park 1, The Green Community, P.O. Box: 34924,
Dubai

Contact: Jason Dodds - Managing Director
Tel: +971 4 885 1001

Fax: +971 4 885 4004

Email: middle.east@exova.com

Click to view dynamic map